Kangji Medical Holdings Limited (9997.HK)

HKD 6.52

(-1.21%)

Market Cap (In HKD)

7.7 Billion

Revenue (In HKD)

926.02 Million

Net Income (In HKD)

504.02 Million

Avg. Volume

404.58 Thousand

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4.91-8.2
PE
-
EPS
-
Beta Value
0.283
ISIN
KYG5215A1004
CUSIP
G5215A100
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Ming Zhong
Employee Count
-
Website
https://www.kangjimedical.com
Ipo Date
2020-06-29
Details
Kangji Medical Holdings Limited, through its subsidiaries, designs, develops, manufactures, and sale of minimally invasive surgical instruments and accessories in China. It offers disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, ultrasonic scalpels, and other types of disposable hand-held instruments; and reusable trocars, reusable forceps, and other reusable products. The company's products are used in obstetrics and gynecology, general surgery, urology, and thoracic surgery specialties. It primarily sells products to a network of distributors. The company was founded in 2004 and is headquartered in Hangzhou, China.